VUMC Main Calendar Events

  • 11/15/2017
    12:15 pm - 1:15 pm
    VICB Seminar, Robert Garbaccio, Merck, 'An Antibody-Drug Conjugate Approach to Tissue-Selective Glucocorticoids'

      The Vanderbilt Institute of Chemical Biology (VICB) presents Dr. Robert Garbaccio, Merck: "An Antibody-Drug Conjugate Approach to Tissue-Selective Glucocorticoids"

    Key Lecture Points
    ·Modality agnostic drug discovery means bringing the best modality to a given biological target
    · Peptide, oligonucleotide and bioconjugate modalities realizing increasing clinical success and address complex biology
    · Organic and medicinal chemists have an important role to play in the discovery and optimization of these alternative modalities
    · The targeted delivery of glucocorticoids to immune cells represents an exciting challenge for chemists to develop novel linker and payload strategies

    Contact: Michelle Armstrong

Find Us On:
YouTube Twitter Facebook
Share on Google+